Pearl River Capital, LLC Bluebird Bio, Inc. Transaction History

Pearl River Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $117,727 - $162,335	-4,281 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$34.44 - $43.75 $147,437 - $187,293	4,281 New	4,281 $231,000
Q2 2019 Aug 12, 2019	SELL	$75.84 - $105.21 $5,915 - $8,206	-78 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$64.44 - $104.11 $5,026 - $8,120	78 New	78 $12,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.